nodes	percent_of_prediction	percent_of_DWPC	metapath
Famciclovir—AOX1—Methotrexate—esophageal cancer	0.777	1	CbGbCtD
Famciclovir—AOX1—Nicotine Metabolism—CYP2A6—esophageal cancer	0.0186	0.152	CbGpPWpGaD
Famciclovir—AOX1—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0128	0.105	CbGpPWpGaD
Famciclovir—AOX1—Effects of Nitric Oxide—NOS2—esophageal cancer	0.00729	0.0598	CbGpPWpGaD
Famciclovir—AOX1—Effects of Nitric Oxide—NOS3—esophageal cancer	0.00586	0.0481	CbGpPWpGaD
Famciclovir—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—esophageal cancer	0.00521	0.0428	CbGpPWpGaD
Famciclovir—AOX1—Tryptophan metabolism—ALDH2—esophageal cancer	0.00387	0.0318	CbGpPWpGaD
Famciclovir—AOX1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00294	0.0241	CbGpPWpGaD
Famciclovir—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.00285	0.0234	CbGpPWpGaD
Famciclovir—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00279	0.0229	CbGpPWpGaD
Famciclovir—AOX1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00276	0.0227	CbGpPWpGaD
Famciclovir—Infection—Carboplatin—esophageal cancer	0.00234	0.0232	CcSEcCtD
Famciclovir—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0022	0.0181	CbGpPWpGaD
Famciclovir—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.00217	0.0215	CcSEcCtD
Famciclovir—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00211	0.021	CcSEcCtD
Famciclovir—Laryngeal pain—Capecitabine—esophageal cancer	0.00209	0.0208	CcSEcCtD
Famciclovir—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00194	0.0159	CbGpPWpGaD
Famciclovir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00193	0.0159	CbGpPWpGaD
Famciclovir—Herpes zoster—Capecitabine—esophageal cancer	0.0019	0.0188	CcSEcCtD
Famciclovir—Body temperature increased—Carboplatin—esophageal cancer	0.00186	0.0185	CcSEcCtD
Famciclovir—Fungal infection—Capecitabine—esophageal cancer	0.00185	0.0183	CcSEcCtD
Famciclovir—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00178	0.0146	CbGpPWpGaD
Famciclovir—Rigors—Capecitabine—esophageal cancer	0.00175	0.0173	CcSEcCtD
Famciclovir—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00171	0.014	CbGpPWpGaD
Famciclovir—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00163	0.0134	CbGpPWpGaD
Famciclovir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00157	0.0156	CcSEcCtD
Famciclovir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00152	0.0125	CbGpPWpGaD
Famciclovir—Renal failure acute—Cisplatin—esophageal cancer	0.00152	0.0151	CcSEcCtD
Famciclovir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00148	0.0121	CbGpPWpGaD
Famciclovir—Herpes zoster—Methotrexate—esophageal cancer	0.00141	0.014	CcSEcCtD
Famciclovir—Fungal infection—Methotrexate—esophageal cancer	0.00138	0.0136	CcSEcCtD
Famciclovir—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00136	0.0112	CbGpPWpGaD
Famciclovir—Face oedema—Cisplatin—esophageal cancer	0.00136	0.0134	CcSEcCtD
Famciclovir—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00128	0.0105	CbGpPWpGaD
Famciclovir—Nasopharyngitis—Cisplatin—esophageal cancer	0.00126	0.0125	CcSEcCtD
Famciclovir—Sweating increased—Cisplatin—esophageal cancer	0.00118	0.0117	CcSEcCtD
Famciclovir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00117	0.0116	CcSEcCtD
Famciclovir—Abdominal discomfort—Cisplatin—esophageal cancer	0.00116	0.0115	CcSEcCtD
Famciclovir—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00112	0.0111	CcSEcCtD
Famciclovir—Renal failure acute—Capecitabine—esophageal cancer	0.00112	0.0111	CcSEcCtD
Famciclovir—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00107	0.00878	CbGpPWpGaD
Famciclovir—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00103	0.00845	CbGpPWpGaD
Famciclovir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00102	0.0102	CcSEcCtD
Famciclovir—Migraine—Capecitabine—esophageal cancer	0.00102	0.0101	CcSEcCtD
Famciclovir—Face oedema—Capecitabine—esophageal cancer	0.001	0.00991	CcSEcCtD
Famciclovir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000982	0.00806	CbGpPWpGaD
Famciclovir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000982	0.00806	CbGpPWpGaD
Famciclovir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000957	0.00948	CcSEcCtD
Famciclovir—Abdominal pain upper—Capecitabine—esophageal cancer	0.000947	0.00938	CcSEcCtD
Famciclovir—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000939	0.0077	CbGpPWpGaD
Famciclovir—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000933	0.00925	CcSEcCtD
Famciclovir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000927	0.00918	CcSEcCtD
Famciclovir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000919	0.00754	CbGpPWpGaD
Famciclovir—Tinnitus—Cisplatin—esophageal cancer	0.000907	0.00898	CcSEcCtD
Famciclovir—Cardiac disorder—Cisplatin—esophageal cancer	0.000903	0.00894	CcSEcCtD
Famciclovir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000876	0.00719	CbGpPWpGaD
Famciclovir—Sweating increased—Capecitabine—esophageal cancer	0.000873	0.00864	CcSEcCtD
Famciclovir—Abdominal discomfort—Capecitabine—esophageal cancer	0.000859	0.00851	CcSEcCtD
Famciclovir—Neutropenia—Capecitabine—esophageal cancer	0.000838	0.0083	CcSEcCtD
Famciclovir—Renal failure acute—Methotrexate—esophageal cancer	0.000836	0.00828	CcSEcCtD
Famciclovir—Flatulence—Cisplatin—esophageal cancer	0.000834	0.00827	CcSEcCtD
Famciclovir—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000833	0.00825	CcSEcCtD
Famciclovir—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00083	0.00681	CbGpPWpGaD
Famciclovir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000809	0.00664	CbGpPWpGaD
Famciclovir—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	0.000795	0.00652	CbGpPWpGaD
Famciclovir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000792	0.00784	CcSEcCtD
Famciclovir—Anaemia—Cisplatin—esophageal cancer	0.000783	0.00775	CcSEcCtD
Famciclovir—Jaundice—Capecitabine—esophageal cancer	0.000778	0.00771	CcSEcCtD
Famciclovir—Leukopenia—Cisplatin—esophageal cancer	0.000758	0.00751	CcSEcCtD
Famciclovir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000755	0.00748	CcSEcCtD
Famciclovir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000735	0.00603	CbGpPWpGaD
Famciclovir—Myalgia—Cisplatin—esophageal cancer	0.000721	0.00714	CcSEcCtD
Famciclovir—Anxiety—Cisplatin—esophageal cancer	0.000718	0.00712	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000716	0.00709	CcSEcCtD
Famciclovir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000712	0.00706	CcSEcCtD
Famciclovir—Pharyngitis—Capecitabine—esophageal cancer	0.000712	0.00705	CcSEcCtD
Famciclovir—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000695	0.00688	CcSEcCtD
Famciclovir—Infection—Cisplatin—esophageal cancer	0.000687	0.0068	CcSEcCtD
Famciclovir—Erythema multiforme—Capecitabine—esophageal cancer	0.000678	0.00672	CcSEcCtD
Famciclovir—Nervous system disorder—Cisplatin—esophageal cancer	0.000678	0.00671	CcSEcCtD
Famciclovir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000677	0.0067	CcSEcCtD
Famciclovir—Skin disorder—Cisplatin—esophageal cancer	0.000671	0.00665	CcSEcCtD
Famciclovir—Tinnitus—Capecitabine—esophageal cancer	0.000668	0.00662	CcSEcCtD
Famciclovir—Hyperhidrosis—Cisplatin—esophageal cancer	0.000668	0.00662	CcSEcCtD
Famciclovir—Cardiac disorder—Capecitabine—esophageal cancer	0.000665	0.00659	CcSEcCtD
Famciclovir—Anorexia—Cisplatin—esophageal cancer	0.000659	0.00653	CcSEcCtD
Famciclovir—Chills—Capecitabine—esophageal cancer	0.000643	0.00637	CcSEcCtD
Famciclovir—Abdominal discomfort—Methotrexate—esophageal cancer	0.000639	0.00633	CcSEcCtD
Famciclovir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00063	0.00624	CcSEcCtD
Famciclovir—Mental disorder—Capecitabine—esophageal cancer	0.000628	0.00622	CcSEcCtD
Famciclovir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000624	0.00512	CbGpPWpGaD
Famciclovir—Neutropenia—Methotrexate—esophageal cancer	0.000624	0.00618	CcSEcCtD
Famciclovir—Paraesthesia—Cisplatin—esophageal cancer	0.00062	0.00615	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00062	0.00509	CbGpPWpGaD
Famciclovir—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00062	0.00614	CcSEcCtD
Famciclovir—AOX1—Disease—SLC52A3—esophageal cancer	0.000617	0.00506	CbGpPWpGaD
Famciclovir—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000616	0.00505	CbGpPWpGaD
Famciclovir—Flatulence—Capecitabine—esophageal cancer	0.000615	0.00609	CcSEcCtD
Famciclovir—Back pain—Capecitabine—esophageal cancer	0.000604	0.00598	CcSEcCtD
Famciclovir—Decreased appetite—Cisplatin—esophageal cancer	0.000601	0.00595	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000597	0.00591	CcSEcCtD
Famciclovir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000589	0.00584	CcSEcCtD
Famciclovir—AOX1—Disease—KMT2D—esophageal cancer	0.000588	0.00483	CbGpPWpGaD
Famciclovir—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000585	0.0048	CbGpPWpGaD
Famciclovir—Anaemia—Capecitabine—esophageal cancer	0.000577	0.00572	CcSEcCtD
Famciclovir—Feeling abnormal—Cisplatin—esophageal cancer	0.000569	0.00564	CcSEcCtD
Famciclovir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000562	0.00557	CcSEcCtD
Famciclovir—Leukopenia—Capecitabine—esophageal cancer	0.000559	0.00553	CcSEcCtD
Famciclovir—Palpitations—Capecitabine—esophageal cancer	0.000552	0.00546	CcSEcCtD
Famciclovir—Body temperature increased—Cisplatin—esophageal cancer	0.000546	0.00541	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000544	0.00446	CbGpPWpGaD
Famciclovir—Myalgia—Capecitabine—esophageal cancer	0.000531	0.00526	CcSEcCtD
Famciclovir—Arthralgia—Capecitabine—esophageal cancer	0.000531	0.00526	CcSEcCtD
Famciclovir—Pharyngitis—Methotrexate—esophageal cancer	0.00053	0.00525	CcSEcCtD
Famciclovir—Anxiety—Capecitabine—esophageal cancer	0.00053	0.00525	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000528	0.00523	CcSEcCtD
Famciclovir—Dry mouth—Capecitabine—esophageal cancer	0.00052	0.00515	CcSEcCtD
Famciclovir—AOX1—Metabolism—BLVRB—esophageal cancer	0.000516	0.00424	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—SLC52A3—esophageal cancer	0.000516	0.00424	CbGpPWpGaD
Famciclovir—Confusional state—Capecitabine—esophageal cancer	0.000514	0.00509	CcSEcCtD
Famciclovir—Infection—Capecitabine—esophageal cancer	0.000506	0.00501	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000506	0.00415	CbGpPWpGaD
Famciclovir—Erythema multiforme—Methotrexate—esophageal cancer	0.000505	0.005	CcSEcCtD
Famciclovir—Nervous system disorder—Capecitabine—esophageal cancer	0.0005	0.00495	CcSEcCtD
Famciclovir—Thrombocytopenia—Capecitabine—esophageal cancer	0.000499	0.00494	CcSEcCtD
Famciclovir—Tinnitus—Methotrexate—esophageal cancer	0.000498	0.00493	CcSEcCtD
Famciclovir—Asthenia—Cisplatin—esophageal cancer	0.000496	0.00491	CcSEcCtD
Famciclovir—Cardiac disorder—Methotrexate—esophageal cancer	0.000495	0.00491	CcSEcCtD
Famciclovir—Skin disorder—Capecitabine—esophageal cancer	0.000495	0.0049	CcSEcCtD
Famciclovir—Hyperhidrosis—Capecitabine—esophageal cancer	0.000492	0.00488	CcSEcCtD
Famciclovir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000488	0.004	CbGpPWpGaD
Famciclovir—Anorexia—Capecitabine—esophageal cancer	0.000486	0.00481	CcSEcCtD
Famciclovir—Chills—Methotrexate—esophageal cancer	0.000479	0.00474	CcSEcCtD
Famciclovir—Diarrhoea—Cisplatin—esophageal cancer	0.000473	0.00468	CcSEcCtD
Famciclovir—Mental disorder—Methotrexate—esophageal cancer	0.000468	0.00463	CcSEcCtD
Famciclovir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000465	0.00381	CbGpPWpGaD
Famciclovir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000464	0.0046	CcSEcCtD
Famciclovir—Insomnia—Capecitabine—esophageal cancer	0.000461	0.00456	CcSEcCtD
Famciclovir—Paraesthesia—Capecitabine—esophageal cancer	0.000457	0.00453	CcSEcCtD
Famciclovir—AOX1—Disease—FKBP1A—esophageal cancer	0.000456	0.00374	CbGpPWpGaD
Famciclovir—Back pain—Methotrexate—esophageal cancer	0.000449	0.00445	CcSEcCtD
Famciclovir—Dyspepsia—Capecitabine—esophageal cancer	0.000448	0.00444	CcSEcCtD
Famciclovir—AOX1—Disease—DOCK2—esophageal cancer	0.000446	0.00366	CbGpPWpGaD
Famciclovir—AOX1—Disease—WIF1—esophageal cancer	0.000446	0.00366	CbGpPWpGaD
Famciclovir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000444	0.00365	CbGpPWpGaD
Famciclovir—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000443	0.00364	CbGpPWpGaD
Famciclovir—Decreased appetite—Capecitabine—esophageal cancer	0.000443	0.00439	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00044	0.00436	CcSEcCtD
Famciclovir—Vomiting—Cisplatin—esophageal cancer	0.000439	0.00435	CcSEcCtD
Famciclovir—Fatigue—Capecitabine—esophageal cancer	0.000439	0.00435	CcSEcCtD
Famciclovir—AOX1—Metabolism—CA1—esophageal cancer	0.000439	0.0036	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—SLC10A2—esophageal cancer	0.000439	0.0036	CbGpPWpGaD
Famciclovir—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000439	0.0036	CbGpPWpGaD
Famciclovir—Rash—Cisplatin—esophageal cancer	0.000436	0.00432	CcSEcCtD
Famciclovir—Constipation—Capecitabine—esophageal cancer	0.000436	0.00432	CcSEcCtD
Famciclovir—Dermatitis—Cisplatin—esophageal cancer	0.000435	0.00431	CcSEcCtD
Famciclovir—Anaemia—Methotrexate—esophageal cancer	0.000429	0.00425	CcSEcCtD
Famciclovir—Feeling abnormal—Capecitabine—esophageal cancer	0.00042	0.00416	CcSEcCtD
Famciclovir—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000417	0.00342	CbGpPWpGaD
Famciclovir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000417	0.00413	CcSEcCtD
Famciclovir—Leukopenia—Methotrexate—esophageal cancer	0.000416	0.00412	CcSEcCtD
Famciclovir—AOX1—Disease—CSNK1A1—esophageal cancer	0.000411	0.00338	CbGpPWpGaD
Famciclovir—Nausea—Cisplatin—esophageal cancer	0.00041	0.00407	CcSEcCtD
Famciclovir—Urticaria—Capecitabine—esophageal cancer	0.000405	0.00401	CcSEcCtD
Famciclovir—Body temperature increased—Capecitabine—esophageal cancer	0.000403	0.00399	CcSEcCtD
Famciclovir—Abdominal pain—Capecitabine—esophageal cancer	0.000403	0.00399	CcSEcCtD
Famciclovir—AOX1—Metabolism—CA2—esophageal cancer	0.000402	0.0033	CbGpPWpGaD
Famciclovir—Myalgia—Methotrexate—esophageal cancer	0.000396	0.00392	CcSEcCtD
Famciclovir—Arthralgia—Methotrexate—esophageal cancer	0.000396	0.00392	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000393	0.00389	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000383	0.00314	CbGpPWpGaD
Famciclovir—Confusional state—Methotrexate—esophageal cancer	0.000382	0.00379	CcSEcCtD
Famciclovir—Infection—Methotrexate—esophageal cancer	0.000377	0.00373	CcSEcCtD
Famciclovir—AOX1—Metabolism—PLCE1—esophageal cancer	0.000373	0.00306	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—ADH7—esophageal cancer	0.000373	0.00306	CbGpPWpGaD
Famciclovir—Nervous system disorder—Methotrexate—esophageal cancer	0.000372	0.00368	CcSEcCtD
Famciclovir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000371	0.00368	CcSEcCtD
Famciclovir—Skin disorder—Methotrexate—esophageal cancer	0.000368	0.00365	CcSEcCtD
Famciclovir—Hyperhidrosis—Methotrexate—esophageal cancer	0.000367	0.00363	CcSEcCtD
Famciclovir—Asthenia—Capecitabine—esophageal cancer	0.000365	0.00362	CcSEcCtD
Famciclovir—Anorexia—Methotrexate—esophageal cancer	0.000361	0.00358	CcSEcCtD
Famciclovir—Pruritus—Capecitabine—esophageal cancer	0.00036	0.00357	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00036	0.00296	CbGpPWpGaD
Famciclovir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000358	0.00294	CbGpPWpGaD
Famciclovir—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000354	0.0029	CbGpPWpGaD
Famciclovir—Diarrhoea—Capecitabine—esophageal cancer	0.000349	0.00345	CcSEcCtD
Famciclovir—AOX1—Disease—ELMO1—esophageal cancer	0.000346	0.00284	CbGpPWpGaD
Famciclovir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000345	0.00342	CcSEcCtD
Famciclovir—Insomnia—Methotrexate—esophageal cancer	0.000343	0.0034	CcSEcCtD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000342	0.0028	CbGpPWpGaD
Famciclovir—Paraesthesia—Methotrexate—esophageal cancer	0.00034	0.00337	CcSEcCtD
Famciclovir—AOX1—Disease—GSTO1—esophageal cancer	0.000338	0.00277	CbGpPWpGaD
Famciclovir—AOX1—Disease—TPI1—esophageal cancer	0.000338	0.00277	CbGpPWpGaD
Famciclovir—Somnolence—Methotrexate—esophageal cancer	0.000337	0.00334	CcSEcCtD
Famciclovir—Dizziness—Capecitabine—esophageal cancer	0.000337	0.00334	CcSEcCtD
Famciclovir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000337	0.00276	CbGpPWpGaD
Famciclovir—Dyspepsia—Methotrexate—esophageal cancer	0.000334	0.00331	CcSEcCtD
Famciclovir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000332	0.00273	CbGpPWpGaD
Famciclovir—Decreased appetite—Methotrexate—esophageal cancer	0.00033	0.00327	CcSEcCtD
Famciclovir—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000329	0.0027	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—ADH1B—esophageal cancer	0.000327	0.00269	CbGpPWpGaD
Famciclovir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000327	0.00324	CcSEcCtD
Famciclovir—Fatigue—Methotrexate—esophageal cancer	0.000327	0.00324	CcSEcCtD
Famciclovir—AOX1—Disease—ALDOB—esophageal cancer	0.000324	0.00266	CbGpPWpGaD
Famciclovir—Vomiting—Capecitabine—esophageal cancer	0.000324	0.00321	CcSEcCtD
Famciclovir—Rash—Capecitabine—esophageal cancer	0.000321	0.00318	CcSEcCtD
Famciclovir—Dermatitis—Capecitabine—esophageal cancer	0.000321	0.00318	CcSEcCtD
Famciclovir—Headache—Capecitabine—esophageal cancer	0.000319	0.00316	CcSEcCtD
Famciclovir—AOX1—Metabolism—TYMP—esophageal cancer	0.000313	0.00257	CbGpPWpGaD
Famciclovir—Feeling abnormal—Methotrexate—esophageal cancer	0.000312	0.0031	CcSEcCtD
Famciclovir—AOX1—Disease—HIST1H2BM—esophageal cancer	0.000312	0.00256	CbGpPWpGaD
Famciclovir—AOX1—Disease—GAPDH—esophageal cancer	0.000312	0.00256	CbGpPWpGaD
Famciclovir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00031	0.00307	CcSEcCtD
Famciclovir—AOX1—Metabolism—CYP26A1—esophageal cancer	0.000304	0.0025	CbGpPWpGaD
Famciclovir—Nausea—Capecitabine—esophageal cancer	0.000303	0.003	CcSEcCtD
Famciclovir—Urticaria—Methotrexate—esophageal cancer	0.000301	0.00298	CcSEcCtD
Famciclovir—Abdominal pain—Methotrexate—esophageal cancer	0.0003	0.00297	CcSEcCtD
Famciclovir—Body temperature increased—Methotrexate—esophageal cancer	0.0003	0.00297	CcSEcCtD
Famciclovir—AOX1—Metabolism—ALOX15—esophageal cancer	0.000297	0.00243	CbGpPWpGaD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00029	0.00238	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000289	0.00237	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—GSTO1—esophageal cancer	0.000283	0.00232	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—TPI1—esophageal cancer	0.000283	0.00232	CbGpPWpGaD
Famciclovir—AOX1—Disease—XIAP—esophageal cancer	0.000275	0.00226	CbGpPWpGaD
Famciclovir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000273	0.00224	CbGpPWpGaD
Famciclovir—Asthenia—Methotrexate—esophageal cancer	0.000272	0.0027	CcSEcCtD
Famciclovir—AOX1—Metabolism—ALDOB—esophageal cancer	0.000271	0.00223	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000269	0.0022	CbGpPWpGaD
Famciclovir—Pruritus—Methotrexate—esophageal cancer	0.000268	0.00266	CcSEcCtD
Famciclovir—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000265	0.00217	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—GAPDH—esophageal cancer	0.000261	0.00214	CbGpPWpGaD
Famciclovir—Diarrhoea—Methotrexate—esophageal cancer	0.000259	0.00257	CcSEcCtD
Famciclovir—AOX1—Metabolism—CRABP1—esophageal cancer	0.000259	0.00212	CbGpPWpGaD
Famciclovir—AOX1—Disease—B2M—esophageal cancer	0.000256	0.0021	CbGpPWpGaD
Famciclovir—Dizziness—Methotrexate—esophageal cancer	0.000251	0.00248	CcSEcCtD
Famciclovir—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00025	0.00205	CbGpPWpGaD
Famciclovir—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000246	0.00202	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—GNG7—esophageal cancer	0.000246	0.00202	CbGpPWpGaD
Famciclovir—AOX1—Disease—ENO1—esophageal cancer	0.000245	0.00201	CbGpPWpGaD
Famciclovir—AOX1—Disease—PSME2—esophageal cancer	0.000242	0.00199	CbGpPWpGaD
Famciclovir—AOX1—Disease—PSME1—esophageal cancer	0.000242	0.00199	CbGpPWpGaD
Famciclovir—Vomiting—Methotrexate—esophageal cancer	0.000241	0.00239	CcSEcCtD
Famciclovir—Rash—Methotrexate—esophageal cancer	0.000239	0.00237	CcSEcCtD
Famciclovir—Dermatitis—Methotrexate—esophageal cancer	0.000239	0.00237	CcSEcCtD
Famciclovir—Headache—Methotrexate—esophageal cancer	0.000238	0.00235	CcSEcCtD
Famciclovir—AOX1—Disease—CALR—esophageal cancer	0.000232	0.00191	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—ALDH2—esophageal cancer	0.000231	0.00189	CbGpPWpGaD
Famciclovir—Nausea—Methotrexate—esophageal cancer	0.000225	0.00223	CcSEcCtD
Famciclovir—AOX1—Disease—FBXW7—esophageal cancer	0.000225	0.00184	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—GSTT1—esophageal cancer	0.000219	0.0018	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—CYP2A6—esophageal cancer	0.000217	0.00178	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—PTGS1—esophageal cancer	0.000206	0.00169	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—ENO1—esophageal cancer	0.000206	0.00169	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000204	0.00167	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—PSME2—esophageal cancer	0.000203	0.00166	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—PSME1—esophageal cancer	0.000203	0.00166	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000194	0.00159	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000191	0.00157	CbGpPWpGaD
Famciclovir—AOX1—Disease—TGFBR2—esophageal cancer	0.000182	0.00149	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000181	0.00149	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—CYP1B1—esophageal cancer	0.000175	0.00143	CbGpPWpGaD
Famciclovir—AOX1—Disease—SMAD4—esophageal cancer	0.000172	0.00141	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—CYP19A1—esophageal cancer	0.000164	0.00135	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000154	0.00127	CbGpPWpGaD
Famciclovir—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000152	0.00125	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—HMOX1—esophageal cancer	0.00015	0.00123	CbGpPWpGaD
Famciclovir—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000145	0.00119	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—ABCB1—esophageal cancer	0.000144	0.00118	CbGpPWpGaD
Famciclovir—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000143	0.00117	CbGpPWpGaD
Famciclovir—AOX1—Disease—HIF1A—esophageal cancer	0.000141	0.00115	CbGpPWpGaD
Famciclovir—AOX1—Disease—NOS2—esophageal cancer	0.000128	0.00105	CbGpPWpGaD
Famciclovir—AOX1—Disease—NOTCH1—esophageal cancer	0.000127	0.00104	CbGpPWpGaD
Famciclovir—AOX1—Disease—CREBBP—esophageal cancer	0.000115	0.000943	CbGpPWpGaD
Famciclovir—AOX1—Disease—NOS3—esophageal cancer	0.000103	0.000844	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—CREBBP—esophageal cancer	9.62e-05	0.00079	CbGpPWpGaD
Famciclovir—AOX1—Disease—ERBB2—esophageal cancer	9.62e-05	0.00079	CbGpPWpGaD
Famciclovir—AOX1—Disease—PTGS2—esophageal cancer	9.41e-05	0.000772	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—NOS3—esophageal cancer	8.61e-05	0.000707	CbGpPWpGaD
Famciclovir—AOX1—Disease—CDKN1A—esophageal cancer	8.22e-05	0.000675	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—PTGS2—esophageal cancer	7.88e-05	0.000647	CbGpPWpGaD
Famciclovir—AOX1—Disease—EP300—esophageal cancer	7.82e-05	0.000642	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—SLC52A3—esophageal cancer	7.79e-05	0.00064	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—BLVRB—esophageal cancer	7.79e-05	0.00064	CbGpPWpGaD
Famciclovir—AOX1—Disease—MYC—esophageal cancer	6.82e-05	0.00056	CbGpPWpGaD
Famciclovir—AOX1—Disease—EGFR—esophageal cancer	6.67e-05	0.000547	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CA1—esophageal cancer	6.63e-05	0.000544	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.63e-05	0.000544	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—EP300—esophageal cancer	6.55e-05	0.000538	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CA2—esophageal cancer	6.06e-05	0.000497	CbGpPWpGaD
Famciclovir—AOX1—Disease—PIK3CA—esophageal cancer	5.79e-05	0.000475	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ADH7—esophageal cancer	5.63e-05	0.000462	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.63e-05	0.000462	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.94e-05	0.000405	CbGpPWpGaD
Famciclovir—AOX1—Metabolism—PIK3CA—esophageal cancer	4.85e-05	0.000398	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—TYMP—esophageal cancer	4.72e-05	0.000387	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.59e-05	0.000377	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.48e-05	0.000367	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—TPI1—esophageal cancer	4.27e-05	0.00035	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.27e-05	0.00035	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.09e-05	0.000336	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.94e-05	0.000323	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.91e-05	0.000321	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—GNG7—esophageal cancer	3.71e-05	0.000305	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.48e-05	0.000286	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.31e-05	0.000272	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.27e-05	0.000269	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.1e-05	0.000255	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ENO1—esophageal cancer	3.1e-05	0.000255	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PSME2—esophageal cancer	3.06e-05	0.000251	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PSME1—esophageal cancer	3.06e-05	0.000251	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.64e-05	0.000217	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.48e-05	0.000204	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.26e-05	0.000186	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.17e-05	0.000178	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.45e-05	0.000119	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—NOS3—esophageal cancer	1.3e-05	0.000107	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.19e-05	9.76e-05	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—EP300—esophageal cancer	9.89e-06	8.12e-05	CbGpPWpGaD
Famciclovir—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.31e-06	6e-05	CbGpPWpGaD
